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Abstract
Background: In spite of great advances in target-oriented Western medicine for treating myocardial infarction (MI), it is still
a leading cause of death in a worldwide epidemic. In contrast to Western medicine, Traditional Chinese medicine (TCM) uses
a holistic and synergistic approach to restore the balance of Yin-Yang of body energy so the body’s normal function can be
restored. Sini decoction (SND) is a well-known formula of TCM which has been used to treat MI for many years. However, its
holistic activity evaluation and mechanistic understanding are still lacking due to its complex components.
Methodology/Principal Findings: A urinary metabonomic method based on nuclear magnetic resonance and ultra high-
performance liquid chromatography coupled to mass spectrometry was developed to characterize MI-related metabolic
profiles and delineate the effect of SND on MI. With Elastic Net for classification and selection of biomarkers, nineteen
potential biomarkers in rat urine were screened out, primarily related to myocardial energy metabolism, including the
glycolysis, citrate cycle, amino acid metabolism, purine metabolism and pyrimidine metabolism. With the altered
metabolism pathways as possible drug targets, we systematically analyze the therapeutic effect of SND, which
demonstrated that SND administration could provide satisfactory effect on MI through partially regulating the perturbed
myocardial energy metabolism.
Conclusions/Significance: Our results showed that metabonomic approach offers a useful tool to identify MI-related
biomarkers and provides a new methodological cue for systematically dissecting the underlying efficacies and mechanisms
of TCM in treating MI.
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Introduction
Myocardial infarction (MI) has emerged as a major public
health hazard. Evidence based medicine has resulted in the
acceptance of nitrodilators, angiotensin converting enzyme
inhibitors, angiotensin receptor blockers and anti-thrombotics as
the standard treatment. In spite of great advances in drug
treatment, it is still a leading cause of death in a worldwide
epidemic [1,2]. There is therefore an urgent need to discover new
modalities of treatment for MI.
In contrast to target-oriented Western medicine, Traditional
Chinese medicine (TCM) uses a holistic and synergistic approach
to restore the balance of Yin-Yang of body energy so the body’s
normal function, or homeostasis, can be restored [3,4]. Sini
decoction (SND) is a representative TCM, which is officially
recorded in Chinese pharmacopoeia 2010 edition and has been
used to treat cardiovascular disease for many years [5,6,7]. It is
composed of three medicinal herbs: Acontium carmichaeli, Glycyrrhiza
uralensis and Zingiber officinale. Though many compounds have been
isolated and identified from SND [8], evaluating the holistic
efficacy and clarifying mechanism of the pharmacological action of
SND remain a difficult task due to the mistiness of active
compounds and the unknown synergistic actions of multiple
components. Thus, new methods for activity evaluation and
molecular target/pathway identification of such a multi-compo-
nent medicine are sorely needed to advance the modernization of
TCM.
Metabonomics is a top-down systems biology approach in
which metabolic responses to biological interventions or environ-
mental factors are analyzed and modeled [9,10]. Metabonomics,
monitoring entire pattern of low molecular weight compounds
rather than focusing on individual metabolites, provides insights
into the global metabolic status of entire organism, which is well
coincident with the integrity and systemic feature of TCM [11,12].
It has shown great promise to understanding disease mechanisms
and identifying diagnostic biomarkers or drug targets
[13,14,15,16]. Analyzing the changes of metabolite profiles after
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34157treatment by TCM in vitro or in vivo may help dissect their
underlying efficacies and mechanisms of action, and exploit new
ideal drugs ultimately.
Nuclear magnetic resonance (NMR) spectroscopy and liquid
chromatography-mass spectrometry (LC-MS) are the most
frequently used analytical techniques in metabonomics
[17,18,19]. Typically, either NMR or LC-MS is performed, but
since these two techniques are complementary, the parallel use of
these two techniques could achieve the most comprehensive
screening of the entire metabolome. Wilson’s group has illustrated
that the two techniques applied in the same biofluid allowed
different aspects of the metabolome to be investigated
[20,21,22,23].
In this work,
1H NMR and ultra high-performance liquid
chromatography-mass spectrometry (UHPLC-MS) were used to
generate metabolite profiles for the metabonomic analysis of urine
collected from sham, MI model and SND-treated rats. One of the
purposes is to characterize the metabolic changes-related to MI
from NMR and UHPLC-MS analysis to increase the understand-
ing of MI. The other purpose is to assess the therapeutic effects of
SND to dissect the mechanisms of SND.
Results
Echocardiographic and histological assessment
We assessed the systolic function in sham operated and MI rats
compared to MI rats treated with SND using echocardiography. As
shown in Figure 1A using two-dimensional and M-mode
echocardiography, treatment with SND resulted in a significant
improvement in left ventricle (LV) systolic function. Summary data
for the ejection fraction and fractional shortening are shown in
Figure 1B and Figure 1C as well as Table 1 depicting a
significant improvement in ejection fraction and fractional
shortening in MI rats treated with SND at 21 days of follow up
compared to MI alone.
Figure 1D shows photomicrographs of examples of tissue
sections from MI rats treated with SND for 21 days compared to
MI alone or sham-operated hearts after 21 days of follow up. The
MI rats showed evidence of an increase in chamber dilatation
associated with MI at follow up. In contrast, treatment with SND
prevented the development of cardiac dilatation post MI. The
histopathological studies were also confirmed by myocardial
infarct size evaluation. As shown in Figure 1E, compared to
the MI group (29.463.91%), the infarct areas of the SND-treated
group (19.363.50%) were significantly decreased (p,0.01). The
above results indicated that the MI model was successfully
established and the SND treatment had a therapeutic effect on MI.
Urinary metabolite profiling in sham and MI rats by
1H
NMR
Typical
1H NMR spectra of urine samples collected on the 21th
day from different groups are shown in Figure 2. Resonance
assignment was carried out according to the literatures [24,25] and
an in-house database as well as the Metabonomics Toolbox
(http://www.hmdb.ca). Due to the high information content and
complexity of the spectra, multivariate data analysis was applied to
reveal the metabolic changes-related MI. Initially, the unsuper-
vised principal component analysis (PCA) was applied to explore
correlations between sham and MI groups, and a tendency in the
score plot to separate the two classes was detected (R
2=0.48)
(Figure 3A). To further search features that can discriminate
between groups, a unique challenge is posed because the number
of variables is much bigger than the number of observations. The
traditional partial least squares (PLS) method has extensively
applied to selection of biomarkers in the similar metabonomic data
[26]. Unfortunately, it cannot automatically retain good features.
In this study, a recent developed approach, Elastic Net, was used
for biomarker selection. The elastic net simultaneously does
automatic variable selection and continuous shrinkage, and it can
select groups of correlated variables [27]. It is like a stretchable
fishing net that retains ‘all the big fish’. Thus, a variable list that
can successfully discriminate the classes could be automatically
obtained. Figure 3B shows the relationship between lambda and
deviance using the Elastic Net approach for the 193 variables with
4-fold cross-validation. We can found that there was a small
deviance for classification when we selected specific lambda value,
an important parameter in Elastic Net, which can produce a
classifier with 15 variables plus an intercept term. Thus, 15
variables were first selected as the candidates of potential
biomarkers. Some of these segments were found to be from the
same metabolites. After merging the variables from the identical
metabolites, 10 metabolites were collected and considered as the
potential biomarkers (Table 2).
Urinary metabolite profiling in sham and MI rats by
UHPLC-MS
Figure 4 shows typical LC–MS total ion current (TIC)
chromatograms of a urine sample in positive ionization mode
(Figure 4A) and negative ionization mode (Figure 4B). To
examine the stability and repeatability of the method, quality
control (QC) samples were prepared by pooling the same volume
of urine from all samples studied [28,29]. System stability was
evaluated by analysis of a QC sample six times at the beginning of
the batch and then after every three samples. Six common ions in
positive ion mode and in negative ion mode were selected for
method validation, respectively. The result was 5.32%–10.37% for
positive ion mode and 4.78%–9.58% for negative ion mode, which
indicates that the method has good stability.
The raw LC–MS data from metabolic profiling were pretreated
following the procedure described in Section 2.8. Finally, 1345
ions, including ESI
+ and ESI
2 ions, were obtained. Similarly,
PCA and Elastic Net were also applied to LC-MS dataset. In the
PCA scores plot (Figure 5A), the MI group and sham group can
also be well distinguished (R
2=0.57). Figure 5B shows the
relationship between lambda and deviance using the Elastic Net
approach for the 1345 variables with 4-fold cross-validation. It was
found that there was a small deviance for classification when we
selected specific lambda value, which can produce a classifier with
23 variables plus an intercept term. Thus, 23 variables were first
selected as the candidates of potential biomarkers. With further
checking the raw chromatograms, it was found that two sodium
adduct ions of them were from the same metabolites. Finally, 21
metabolites were collected and considered as the potential
biomarkers. Here, we take the ion at m/z 180 ([M+H]
+)as an
example to illustrate the identification process. First, the
corresponding quasi-molecular ion peak was found according to
the retention time in the extracted ion chromatogram (EIC) of m/z
180 (Figure 6A). The exact mass of the quasi-molecular ion was
found as m/z 180.0658. Second, the element composition of the
peak was calculated by Agilent MassHunter software. The
calculated list provided 6 possible element compositions according
to the exact mass and isotope pattern. Third, the elemental
composition was compared to those registered in the freely
accessible databases of HMDB (http://www.hmdb.ca), METLIN
(http://metlin.scripps.edu) and KEGG (http://www.kegg.jp), and
C9H9NO3 was found as the most likely compound. Fourth, a mass
fragmentation experiment was conducted, in which two major
fragment ions were found at m/z 105.033 and 77.038, which
Effect of Sini Decoction on Myocardial Infarction
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+ and [C6H5]
+, respectively.
The standard MS/MS spectrum of possible compounds was then
matched. As a result, the biomarker was identified as hippuric acid
and was finally confirmed by comparison with a standard
compound (Figure 6B and Figure 6C). In this way, 13
metabolites (about 62% of the all) have been identified and listed
in Table 3. However, the remaining biomarkers (data not shown)
were unidentifiable due to insufficient intensity for MS/MS
experiments or the restrictions of current metabolite databases.
Effects of SND based on metabolite profiling
Using the presented
1H NMR and UHPLC-MS method, the
urinary metablic profiles of SND-treated group were obtained. The
therapeutic effects of SND on MI have been shown in Section 3.1.
Figure 1. Echocardiographic and histological analysis. (A) M-mode echocardiography in rat models with sham operation, MI and SND-treated
groups showing evidence of cardiac failure with chamber dilation in MI rat. SND prevented the development of chamber dilatation in MI rats. (B)
Summary data for percentage of ejection fraction (EF) and (C) Summary data for percentage of fractional shortening (FS). Data shown are mean6
S.D., n=7, 6 and 8 for sham, MI, SND-treated groups, respectively. (D) Histologic sections of sham-operated and MI rat hearts, showing gross cardiac
dilatation at the 21th day in the MI rats. Treatment of MI rats with SND prevented the development of cardiac remodeling. (E) Myocardial infarct size
in sham, MI and SND-treated groups. No infarcted area appeared in sham group. Asterik (*) and pound key (#) represent statistically significant
differences compared MI group to sham and SND-treated groups (p,0.05), respectively.
doi:10.1371/journal.pone.0034157.g001
Table 1. Summary of echocardiographic data.
Treatment n LVEDV(mL) LVESV(mL) LVIDd(mm) LVIDs(mm) EF(%) FS(%)
Sham 7 170.94635.26 17.9168.85 5.8760.55 2.1660.66 90.0264.24 63.7869.23
MI alone 6 393.34628.72 248.53619.02 8.8160.90 7.1860.74 36.8062.35
* 18.5261.11
*
MI+SND 8 355.94655.05 187.89633.69 8.1360.50 6.1860.43 47.1965.89
# 23.9963.92
#
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVIDd,left ventricular internal diameter in diastole; LVIDs, left ventricular internal
diameter in systole; EF, ejection fraction; FS, fractional shortening. Data are mean 6 S.D.,
*p,0.05 comparing MI and sham animals,
#p,0.05 comparing SND-treatment and MI animals.
doi:10.1371/journal.pone.0034157.t001
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1H NMR and 13 ones from
UHPLC-MS have been found, it is reasonable to take them as the
potential drug targets for further investigating the intervening
mechanisms of SND to MI. Therefore, the levels of the 10
biomarkers from
1H NMR and the ones of 13 biomarkers from
UHPLC-MS on the 21th day were introduced as variables to
PCA, respectively, performed on sham, MI and SND-treated
groups. The score plots of the first two principal components
allowed visualization of the data and comparing of the three group
samples. The R
2X and Q
2 were 0.793 and 0.601 for
1H NMR and
0. 767 and 0.599 for UHPLC-MS, which indicated the
classifications were well for PCA models with the variables
detected by the respective techniques. As shown in the PCA scores
map derived from urinary levels of ten metabolites using
1H NMR
(Figure 7A), the SND-treated group is closer to the sham group.
Similar result can be found from the PCA scores map derived from
urinary levels of 13 metabolites using UHPLC-MS (Figure 7B).
These results suggested that SND could reverse the pathological
process of MI. To further evaluate the reversed condition of the
potential biomarkers by administration with SND, student’s t-test
was performed by SPSS software. The critical p-value was set to
0.05 for significantly differential variables in this study. The
relative peak areas of the 10 metabolites from
1H NMR and 13
metabolites from UHPLC-MS to their respective total integrated
area of the spectra are shown in Figure 8. Compared to the MI
group from
1H NMR dataset (Figure 8A and Figure 8B), ten
metabolites including lactate, L-alanine, succinate, 2-oxoglutarate,
citrate, creatine, glycine, L-tryptophan, hippuric acid, and N-
methylnicotinamide were significantly reversed in SND-treated
group. Similarly, from UHPLC-MS dataset (Figure 8C and
Figure 8D), the ten of thirteen metabolites including creatine,
uridine, citrate, L-isoleucine, oxalosuccinate, L-tryptophan, hip-
puric acid, cyclic AMP, phenylacetylglycine, and xanthosine were
significantly reversed, and the other three metabolites were also
reverse at different degrees, except for 4-PY (or 2-PY).
Discussion
TCM has been used in China and other Asian countries for
over 5,000 years for the prevention and treatment of a variety of
diseases. A lot of clinical drugs for cardiovascular diseases are
derived from natural products nowadays. Among which, different
Figure 2. Representative 600 MHz
1H NMR spectra of urine from sham (A), MI (B) and SND-treated (C) groups.
doi:10.1371/journal.pone.0034157.g002
Figure 3. Multivariate statistical analysis of data from the
1H
NMR analysis of urine from sham and MI groups. (A) PCA scores
plot: (&) sham group, (m) MI group. (B)The relationship between
lambda and deviance using Elastic Net approach (alpha=0.8).
doi:10.1371/journal.pone.0034157.g003
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based on TCM theory and empirical education. The TCM SND
with long history of use has been proven to be effective in treating
MI. Nevertheless, its holistic activity evaluation and mechanistic
understanding are still lacking.
According to the chemical analysis of SND in our previous study
[8], we found that the major components from SND are aconitum
alkaloids, gingerols, flavonoids, and saponins. It was reported that
aconitum alkaloids can positively influence heart related diseases
when administered in optimum doses [30]. Gingerols have a direct
positive inotropic effect and directly activates SR Ca
2+-ATPase in
mammalian myocardium [31,32]. Several flavonoids and saponins
were also reported to have cardiovascular activities [33]. For
example, Isoliquiritigenin has a vasorelaxant effect [34] and
glabridin can modulate vascular injury and atherogenesis [35].
Glycyrrhizin has an antiplatelet aggregation effect [36]. In
addition, gingerols, flavonoids and saponins have antioxidant
effects [33,37]. Just as the multi-components hit multiple targets to
exert an overall therapeutic effect, it is a great challenge to
characterize the holistic efficacy and understand its action
mechanisms completely.
In this study, both
1H NMR and UHPLC-MS were used to
investigate the urinary metabolic profile associated with MI and
then delineate the effect of TCM SND on MI. Although the
changes in metabolite profiles observed by
1H NMR and UHPLC-
MS with pattern recognition tools were similar, the markers which
indicated the separations of MI group from sham group observed
were different, apart from citrate, creatine, L-tryptophan and
Table 2. Identification of significantly differential metabolites in the rat urine by
1H NMR analysis.
Chemical shift (ppm)
a Metabolite MI group
b SND group
c related pathway
1.34 (d), 4.10 (q) Lactate (*)q (*)Q Glycolysis
1.50 (d) L-alanine (*)q (*)Q Alanine and aspartate
metabolism
2.42 (s) Succinate (*)q (*)Q Citrate cycle
2.46 (t), 3.02 (t) 2-oxoglutarate (*)Q (*)q Citrate cycle
2.54 (d), 2.66 (d) Citrate (*)Q (*)q Citrate cycle
3.06 (s) Creatine (*)Q (*)q Arginine and proline
metabolism
3.58 (s) Glycine (*)q (*)Q Glycine, serine and threonine
metabolism
7.18 (t), 7.34 (s) L-tryptophan (*)Q (*)q Tryptophan metabolism
3.98 (d), 7.82(dd) Hippuric acid (*)Q (*)q Phenylalanine metabolism
4.46 (s),9.30 (s) N-methylnicotinamide (*)q (*)Q Tryptophan metabolism
aLetters in parentheses indicate the peak multiplicities: s, singlet; d, doublet; t, triplet; dd, doublet of doublets; q, quarte; ABX, two coupling.
bcompared to sham group.
ccompared to MI group. Arrow (q) indicates relative increase in signal, Arrow (Q) indicates relative decrease in signal, Asterik (*) represents a statistically significant
difference(p,0.05).
doi:10.1371/journal.pone.0034157.t002
Figure 4. Typical urinary base peak intensity (BPI) chromatograms of sham rats in (A) ESI
+ mode and (B) ESI
2 mode.
doi:10.1371/journal.pone.0034157.g004
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demonstrated that the potential biomarkers revealed by the two
techniques were supplementary, which offered the potential to
assess the perturbed metabolic pathways related to MI. Ultimately,
nineteen potential biomarkers were identified and they distributed
in 12 pathways by searching KEGG PATHWAY Database
(http://www.genome.jp/kegg/). By relating the metabolic path-
ways, the metabolic network of the potential biomarkers changing
for MI and SND modulation is constructed and shown in Figure 9.
Through the examination of Figure 9, we found that most of
the potential biomarkers were involved in metabolic processes
related to myocardial energy metabolism, including the glycolysis,
citrate cycle, amino acid metabolism, purine metabolism and
pyrimidine metabolism. Among which, the citrate cycle is central
to energy metabolism in this network. Under the condition of MI,
ischemia and oxygen deficiency resulted in reduced formation of
adenosine triphosphate (ATP) via aerobic mechanisms and
accelerated anaerobic ATP production by glycolysis [38,39,40].
Therefore, a build-up of lactate, the end product of anaerobic or
nonoxidative glycolysis, was observed in MI group. It has also
been used as a marker of ischemia in clinical practice and
experimental studies [41,42]. Meanwhile, the metabolite profiles
showed the changes of four pivotal intermediates of citrate cycle,
in which a decrease in citrate, oxalosuccinate, and 2-oxoglutarate
and a build-up in succinate were observed in MI group.
Cardiomyocyte levels of citrate cycle intermediates are tightly
regulated to ensure adequate throughput of substrates derived
from glycolysis and fatty acid oxidation [43]. The result indicated
that the citrate cycle was inhibited, which is compatible with the
results of previous studies [39]. The reason for its inhibition was
related to the deficient oxygen and other substrate supply in
mitochondrion.
A decrease in L-isoleucine in the MI group in comparison to the
sham group was observed. L-Isoleucine is one of three branched
chain amino acids (BCAAs, the others are leucine and valine). In
myocardial ischemia, BCAAs derived from the mobilization of
muscle protein may be an important alternative energy substrate
for the heart [44]. It seems that the MI induced reduction of ATP
production by inhibition of citrate cycle and fatty acid oxidation
provoke the utilization of BCAA as an energy reservoir. The
metabolite profiles also showed the changes of other a-amino acids
metabolism, where a build-up in L-alanine and glycine as well as
L-proline and a decrease in L-tryptophan were observed in MI
group. They are important energy metabolism precursors and can
be transformed into some biomolecules, such as pyruvate and
fumarate, to enter into citrate cycle. One possible explanation was
that ischemia and oxygen deficiency lead to their metabolic
remodeling to meet energy requirement in myocardium [45]. In
addition, N-methylnicotinamide, a metabolite of L-tryptophan
detected in this study, was elevated in MI group, which may
further predict the abnormality in the L-tryptophan metabolism in
MI rats.
Figure 5. Multivariate statistical analysis of data from the
1H
NMR analysis of urine from sham and MI groups. (A) PCA scores
plot: (&) sham group, (m) MI group. (B)The relationship between
lambda and deviance using Elastic Net approach (alpha=0.8).
doi:10.1371/journal.pone.0034157.g005
Figure 6. Identification of a selected marker (m/z 180). (A)
Extracted ion chromatogram (EIC) of m/z 180; (B) MS/MS spectrum of
the ion; (C) MS/MS spectrum of a commercial standard hippuric acid.
The collision energy was 15 V.
doi:10.1371/journal.pone.0034157.g006
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after coronary occlusion and reperfusion [46], which was
confirmed in our study. One possible explanation for enhanced
uridine accumulation is a compensatory increase in RNA synthesis
in the ischemic myocardium due to inefficient protein synthesis
[46]. The UHPLC-MS spectra also showed a build-up of cyclic
AMP and a decrease of xanthosine. The two metabolites are both
involved in purine metabolism, which was an important process in
myocardial ischemia injury [47,48]. Among them, Cyclic AMP is
a metabolite of ATP. The reason for its accumulation in urine of
MI rat is probably related to the degradation of ATP. In contrast,
due to the depletion of ATP, its biosynthesis from biomolecules,
such as xanthosine, was compensatorily elevated in response to
MI. This could explain the decreased level of xanthosine in MI
group. Furthermore, a decrease in creatine in the MI group in
comparison to the sham group was observed. It seems that the
decreased level of creatine in serum and urine is a characteristic of
MI [49]. In addition, the level of N2-succinyl-L-ornithine,
hippuric acid, phenylacetylglycine and 4-PY (or 2-PY) was also
changed in MI rat urine. However, it was perplexing correspond-
ing to MI. A further study on the mechanisms of their changes in
MI rats is being carried out in our laboratory.
It was reported that SND could up-regulate B-cell lymphoma 2
(Bcl-2) protein and inhibit activation of Caspase-3 in ischemia-
reperfusion cardiomyocytes, resulting in promoting mitochondrial
function and reducing apoptosis, which might be responsible for
the intervening effect of SND on ischemia injury [7]. In this study,
the down-regulation of lactate, succinate, and L-alanine and up-
regulation of citrate, oxalosuccinate, 2-oxoglutarate, and L-
tryptophan were observed in SND-treated group compared with
MI group, which implied that SND might functionally intervene in
glycolysis and citrate cycle as well as amino acids metabolism. In
fact, SND administration permitted the mean levels of all potential
biomarker to reverse at different degrees, except for 4-PY (or 2-
PY). Combined with the echocardiographic assay, it suggested that
Table 3. Identification of significantly differential metabolites in the rat urine by UHPLC-MS analysis.
No. tR (min) Ion (m/z) Metabolite Ion mode MI group
a SND group
b Related pathway
1 0.74 132.0769 Creatine
c ESI
+ (*)Q (*)q Arginine and proline metabolism
2 0.96 245.0771 Uridine
c ESI
+ (*)q (*)Q Pyrimidine metabolism
3 0.99 191.0195 Citrate
c ESI
2 (*)Q (*)q Citrate cycle
4 1.13 116.0710 L-proline
c ESI
+ (*)q (#)Q Arginine and proline metabolism
5 1.17 153.0656 4-PY or 2-PY
d ESI
+ (*)Q (#)Q Nicotinate and nicotinamide
metabolism
6 1.23 132.1018 L-isoleucine
c ESI
+ (*)Q (*)q Valine, leucine and isoleucine
degradation
7 2.72 188.9865 Oxalosuccinate
c ESI
2 (*)Q (*)q Citrate cycle
8 3.83 205.0970 L-tryptophan
c ESI
+ (*)Q (*)q Tryptophan metabolism
9 5.59 180.0657 Hippuric acid
c ESI
+ (*)Q (*)q Phenylalanine metabolism
10 7.07 328.0420 Cyclic AMP
d ESI
2 (*)q (*)Q Purine metabolism
11 7.11 192.0666 Phenylacetylglycine
d ESI
2 (*)q (*)Q Phenylalanine metabolism
12 8.77 233.0920 N2-Succinyl-L-ornithine
d ESI
+ (*)Q (#)q Arginine and proline metabolism
13 9.04 283.0827 Xanthosine
c ESI
2 (*)Q (*)q Purine metabolism
acompared to control group.
bcompared to MI group.
cMetabolites identified by comparing with database and authentic standard.
dMetabolites identified by comparing with literatures and database resources. Arrow (q) indicates relative increase in signal. Arrow (Q) indicates relative decrease in
signal. Asterik (*) represents a statistically significant difference (P,0.05), whereas pound key (#) represents no statistically significant difference. 4-PY: N-methyl-4-
pyridone-3-carboxamide, 2-PY: N-methyl-2-pyridone-5-carboxamide.
doi:10.1371/journal.pone.0034157.t003
Figure 7. PCA scores plot derived from urine levels of ten
metabolites using
1H NMR (A) and thirteen metabolites using
UHPLC-MS (B) in sham group(&), MI group(N)a n dSND
treatment group (m).
doi:10.1371/journal.pone.0034157.g007
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biomarkers revealed metabolic pathways (glycolysis, citrate cycle,
and amino acids metabolism) might be involved in the intervening
mechanism of SND.
In summary, the myocardial ischemia and oxygen deficiency
would lead to high rate of glycolysis, lactate accumulation,
inhibition of citrate cycle and other disturbed metabolism. This
hypothesis can be confirmed by combination of
1H NMR and
UHPLC-MS with pattern recognition techniques in this study.
With Elastic Net for classification and selection of biomarkers,
nineteen metabolites primarily involved in glycolysis, citrate cycle,
amino acid metabolism, purine metabolism and pyrimidine
metabolism, were screened out and considered as potential
biomarkers corresponding to MI. The
1H NMR and UHPLC–
MS-based urinary metabonomic profiling has been successfully
applied to evaluate the intervening effect of SND. Taking the
potential biomarkers found in this study as possible drug targets, it
revealed that SND could restore the unbalanced myocardial energy
metabolism. However, due to the small number of rats in this
study, our results serve to demonstrate the methodology rather
than to provide definitive conclusions about the disease and drug.
Application of these tracers for the detection of MI-induced
disturbed metabolite status and assessment of the holistic efficacy
of SND in other species including humans awaits further study.
Our results show that combination of high resolution analytical
tools (e.g.,
1H Nuclear Magnetic Resonance Spectroscopy and
Liquid Chromatography/Mass Spectrometry) with pattern recog-
nition techniques provided a new methodological cue for
dissecting the underlying efficacies and mechanisms of TCM.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Administrative
Committee of Experimental Animal Care and Use of Second
Military Medical University (SMMU, Licence No. 2011023), and
conformed to the National Institute of Health guidelines on the
ethical use of animals.
Reagents and materials
Formic acid of HPLC grade was purchased from Tedia (OH,
USA). Acetonitrile of HPLC grade was purchased from Merck
(Darmstadt, Germany). Distilled water was purified using a Milli-
Q system (Millipore, Bedford, MA, USA). Deuterium oxide (D2O,
99.9%) was purchased from Minipul, Norell Inc. (Landisville, NJ,
USA). Oxalosuccinate and xanthosine were purchased from
Sigma-Aldrich (St Louis, MO, USA). The following compounds
were obtained from Shanghai Jingchun Reagent Co.: creatine,
uridine, citrate, L-isoleucine, L-tryptophan, hippuric acid, sodium
Figure 8. Bar plots show
1H NMR relative signal intensities for ten metabolites (A, B) and UHPLC-MS relative signal intensities for
thirteen metabolites (C, D) in sham, MI and SND-treated groups. Data are expressed as mean 6 S.D. Significant differences (p,0.05) exist
between sham and MI for all the metabolites studied.*p,0.05 versus MI group.
doi:10.1371/journal.pone.0034157.g008
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hydrogen phosphate dodecahydrate (Na2HPO4?12H2O).
Acontium carmichaeli (collection in Sichuan, China), Glycyrrhiza
uralensis (collection in Xinjiang, China) and Zingiber officinale
(collection in Guizhuo, China) were purchased from Shanghai
Dekang Medicine Corp. (Shanghai, China) were authenticated by
Lianna Sun (Department of Pharmacognosy, School of Pharmacy,
Second Military Medical University, Shanghai, China).
Preparation of SND
According to the original composition of SND recorded in
Chinese Pharmacopoeia 2010 edition, SND was prepared using the
following procedure. The crude drugs of A. carmichaeli 90 g, Z.
officinale 60 g and G. uralensis 90 g were immersed in 2.4 liter water
for 1 h and then decocted to boil for 2 h. The decoction was
filtered through four layers of gauze. Next, the dregs were boiled
once again for 1 h with 1.9 liters of water and the decoction was
filtrated out with the above method. Afterward, the successive
decoctions were merged and condensed under decompression.
Finally, the extraction solution was made to a concentration of
1.0 g crude drugs/mL. According to our previous published paper
[8], 53 components of SND were identified.
Myocardial infarction mode and drug administration
All of the animal studies followed the relevant national
legislation and local guidelines and were performed at the Centre
of Laboratory Animals of the Second Military Medical University
(Shanghai, China). Twenty-four male Sprague-Dawley rats
(200615 g) were purchased from the Slac Laboratory Animal
Co., LTD (Shanghai, China) and housed in standard conditions.
Myocardial infarction was produced by occlusion of the left
anterior descending coronary artery, as described previously [50].
Anterior thoracotomy was performed under sterile conditions to
open the pericardium. The heart was then rapidly exteriorized.
The left anterior descending coronary artery was ligated
approximately 2–3 mm distal from its origin with use of a 6-0
Figure 9. The network of the potential biomarkers changing for MI and SND modulation according to the KEGG PATHWAY
database. Column value in histograms is expressed as mean 6 S.D., in which the value of citrate, creatine, tryptophan and hippuric acid derived
from UHPLC-MS and those of the other metabolites derived from respective analysis system (UHPLC-MS or
1H NMR). Metabolite names in red and
green represent elevation and inhibition, respectively. Metabolite names in black mean they were not detected in our experiment. The blue italic
words are pathway’s names. PRPP, phosphoribosyl pyrophosphate.
doi:10.1371/journal.pone.0034157.g009
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experiment, including 14 MI rats and 7 sham rats (without
ligation), while 3 animals died after surgery and were excluded.
Eight of 14 MI rats received SND by oral gavage at dose of 10 g/
kg body weight (equal to 10 mL/kg body weight) once daily
between 8:00 and 10:00 a.m. for the following 21 days. The sham
(n=7) and MI (n=6) rats received the same volume of water
vehicle. The physiological examinations were performed 21 days
after heart surgery based on two points. On one hand, the
functional deterioration after left coronary artery ligation is
generally maximal after 3 weeks [51]. On the other hand, TCM
to exert remarkable effects needs more time than western medicine
based on TCM theory. The administration procedure in this study
is in accordance with clinical use.
Sample collection and preparation
Compared to serum metabonomic study, the urine metabo-
nomic study is non-invasion. Therefore, we focus on MI-related
urinary metabolites in this study and samples of 24-h urine were
collected on the 21th day from sham, MI and SND-treaded groups.
Sodium azide was added to the collection vessels as an
antibacterial agent. The fresh urine samples were immediately
centrifuged at 14,0006g for 10 min at 4uC, to remove particle
contaminants, and the supernatants were stored at 280uC until
NMR and UHPLC -MS analysis.
For
1H NMR analysis, an aliquot of 400 mL of urine sample was
mixed with 200 mL phosphate buffer (0.2 M Na2HPO4 and 0.2 M
NaH2PO4; pH 7.4), 50 mL TSP (3-trimethylsilyl-propionic acid;
1 mM final concentration; internal standard) and 50 mL deuteri-
um oxide. The mixture was left to stand for 10 min at room
temperature and then centrifuged at 14,0006g for 15 min at 4uC
in order to remove any precipitates. The supernatant of 600 mL
was transferred into 5-mm o.d. NMR tube.
For UHPLC-MS analysis, 400 mL of methanol was added to
100 mL aliquots of urine. The mixture was vortex-mixed
vigorously for 30 s and subsequently centrifuged at 14,0006g for
15 min at 4uC. The supernatant was transferred to autosampler
vial kept and an aliquot of 4 mL was injected for UHPLC-MS
analysis.
Echocardiography and histology
Echocardiography was performed with Visual Sonics Vevo 770
machine equipped with 23 (or 30) MHz transducers on one day
post-sampling to assess systolic function. Animals were lightly
sedated with 100 mg/kg ketamine (Anhui Wanhe Pharmaceuti-
cals, China). Left ventricular end-systolic volume (LVESV), left
ventricular end-diastolic volume (LVEDV), left ventricular inter-
nal diameter in diastole (LVIDd), and left ventricular internal
diameter in systole (LVIDs) were measured at the level of the
papillary muscles on the short-axis view using 2-dimensional
guided M-mode imaging at 3 cardiac cycles. The left ventricular
(LV) ejection fraction (EF) and fractional shortening (FS) were
taken as measures of LV systolic function [52]. Left ventricular EF
and FS were calculated using EF%=((LVEDV2LVESV)/
LVEDV)6100 and FS (%)=(LVIDd2LVIDs )/LVIDd6100,
respectively.
Hearts were excised, and we randomly split the samples of each
group in half, and use one half of the sample to roughly estimate
chamber dilatation and the other half of the sample to determine
myocardial infarct size. The hearts for estimating chamber
dilatation were retrogradely perfused with phosphate-buffered
solution to wash out blood and fixed in 4% paraformaldehyde.
Hearts were then embedded in tissue OCT-freeze medium and
the long-axis section was taken perpendicular to the horizontal
axis. In order to determine myocardial infarct size, duplicate 1-
mm mid-LV sections of the other frozen hearts were cut and
incubated with 1% triphenyltetrazolium chloride for 20 min at
37uC. The infarct size was determined by planimetry of the infarct
zone and expressed as a percentage of the total LV area using
HPIAS-1000 color pathology picture analysis system.
1H NMR analysis
1H NMR analysis was made on a Bruker AVANCE II 600
spectrometer, operating at 600.13 MHz 1H frequency (Bruker
Spectrospin AG, SWISS). The NMR spectra of the urine samples
were acquired using a solvent pre-saturation pulse sequence to
suppress the residual water resonance. Free induction decays
(FIDs) were collected at 64 k data points, at 300 K, with a spectral
width of 7200 Hz and an acquisition time of 2.04 s, giving a total
pulse recycle delay of 3.04 s. The data were zero filled by a factor
of 2 and the FIDs were multiplied by an exponential weighting
function equivalent to a line broadening of 0.3 Hz prior to Fourier
transformation.
UHPLC-MS analysis
UHPLC-MS analysis was performed on Agilent 1290 Infinity
LC system coupled to Agilent 6530 Accurate-Mass Quadrupole
Time-of-Flight (Q-TOF) mass spectrometer (Agilent, USA).
Chromatographic separations were performed on an ACQUITY
UPLC
TM BEH C18 column (2.1 mm6100 mm, 1.7 mm, Waters,
Milford, MA) maintained at 50uC. The mobile phase consisted of
0.1% formic acid (A) and ACN modified with 0.1% formic acid
(B). The following gradient program was used: 3%B at 0–2 min,
3%–15% B at 2–11 min, 15%–30% B at 11–16 min, 30%–95% B
at 16–18 min, 95% B at 18–19.5 min, 95%-3%B at 19.5–20 min
and followed by re-equilibrated step of 4 min. The flow rate was
400 mL/min and the injection volume was 4 mL.
An electrospray ionization source (ESI) interface was used, and
was set in both positive and negative modes so as to monitor as
many ions as possible. The following parameters were employed:
capillary voltage, 3.5 kV; drying gas flow, 11 L/min; gas
temperature: 350uC; nebulizer pressure, 45 psig. fragmentor
voltage, 120 V; skimmer voltage, 60 V. Data were collected in
centroid mode and the mass range was set at m/z 50–1000 using
extended dynamic range. Potential biomarkers were analyzed by
MS/MS. The collision energy was 15 V.
Data processing
The acquired
1H NMR spectra were manually corrected for
phase and baseline distortions within TOPSPIN (version 3.0,
Bruker Biospin, Germany), and the chemical shifts were
referenced to TSP at 0.0 ppm. Each
1H NMR spectrum was
reduced into 220 integrated segments of equal width (0.04 ppm)
corresponding to the region between 0.60 and 9.40 ppm using
AMIX software (version 3.9.5, Bruker Spectrospin Ltd.). The
spectral regions containing residual water (4.64–5.08 ppm) and
urea resonances (5.56–6.20 ppm) was excluded from the analysis.
All remaining segments (193 segments) of the spectra were then
scaled to the total integrated area of the spectra in order to reduce
any significant concentration differences. The resulting three-
dimensional matrix, including spectral regions (variable indices),
sample names (observations), and normalized integral intensities
(variables), was exported to multivariate data analysis.
The acquired UHPLC-MS raw data in instrument specific
format (.d) were firstly converted to common data format
(.mzData) files using a conversion software program (file converter
program available in Agilent MassHunter Qualitative software), in
which the isotope interferences were eliminated. The program
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nonlinear alignment of the data in the time domain and automatic
integration and extraction of the peak intensities [53]. XCMS
parameters were default settings except for the following: full width
at half maximum (FWHM)=10, bandwidth (bw)=10 and
snthresh=6, due to narrower peaks obtained by the use of the
column packed with 1.7 mm particles. The variables presenting in
at least 80% of either group were extracted [54]. Variables with
less than 30% relative standard deviation (RSD) in QC samples
[28,29] were then retained for further multivariate data analysis
because they were considered stable enough for prolonged LC–
MS analysis. For each chromatogram, the intensity of each ion
was normalized to the total ion intensity, in order to partially
compensate for the concentration bias of metabolites between
samples and to obtain the relative intensity of metabolites. The
resulting three-dimensional matrix, including retention time and
m/z pairs (variable indices), sample names (observations), and
normalized ion intensities (variables), was exported to multivariate
data analysis.
Statistical analysis
Statistically significant differences in mean values were tested by
using 2-tailed, 2-sample Student’s t-test, and p,0.05 was
considered statistically significant.
Prior to multivariate analysis, the resultant data matrices from
two analytical techniques were mean-centered and paretoscaled.
The PCA using SIMCA-P (version 11, Umetrics) was used to
uncover unknown trends in the sham, MI, and SND-treated
groups. The Elastic Net using the library ‘‘glmnet’’ in the R
environment (http://www.r-project.org) was used for classification
and selection of significant ion peaks between sham and MI
groups.
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